Warburg Pincus-Backed AI Drug Firm Insilico Weighs U.S. IPO

Warburg Pincus-Backed AI Drug Firm Insilico Weighs U.S. IPO

Insilico Medicine, a company that uses artificial intelligence to drive drug discovery, is considering a U.S. IPO that could raise about $300m, according to people familiar with the matter. The Hong Kong-based firm is in talks with investment banks about a possible...
Infrastructure Fundraising Bounced Back in 2021’s First Half

Infrastructure Fundraising Bounced Back in 2021’s First Half

Investors are pouring money into infrastructure funds, which are on the rebound after proving their resiliency during last year’s pandemic-related downturn. In the first six months of 2021, $54.8bn was raised globally for infrastructure deals, with $31.8bn of that in...
TPG Sets $7bn Upper Limit on Its Rise Climate Fund

TPG Sets $7bn Upper Limit on Its Rise Climate Fund

Private equity firm TPG has set a $7bn upper limit on fundraising for its debut climate-related investment pool to back companies that are expected to have a positive impact on the environment by reducing carbon emissions, according to public documents prepared for...
Apax-backed Paycor valued at $4.8bn in Nasdaq debut as shares rise

Apax-backed Paycor valued at $4.8bn in Nasdaq debut as shares rise

Shares of Paycor HCM Inc jumped 20% in their Nasdaq debut on Wednesday, giving a valuation of $4.8 billion for the human capital management firm that primarily caters to small and medium-sized businesses. The stock opened at $28 per share, above the IPO price of $23....